For research use only. Not for therapeutic Use.
Atinvicitinib（Cat No.:I045121）is an investigational oral Janus kinase (JAK) inhibitor designed to selectively target JAK1 and JAK3, key mediators of cytokine signaling involved in autoimmune and inflammatory diseases. By modulating the JAK-STAT pathway, Atinvicitinib reduces the activity of pro-inflammatory cytokines such as IL-2, IL-6, and IFN-γ. It is being studied for conditions like rheumatoid arthritis, inflammatory bowel disease, and other immune-mediated disorders. Atinvicitinib aims to offer a balanced efficacy and safety profile with minimized off-target effects. Supplied for research into cytokine signaling, immune modulation, and targeted anti-inflammatory therapies.
| CAS Number | 2169273-59-8 |
| Synonyms | 1-[(3R,4S)-4-cyanooxan-3-yl]-3-[(2-fluoro-6-methoxypyridin-4-yl)amino]pyrazole-4-carboxamide |
| Molecular Formula | C16H17FN6O3 |
| Purity | ≥95% |
| IUPAC Name | 1-[(3R,4S)-4-cyanooxan-3-yl]-3-[(2-fluoro-6-methoxypyridin-4-yl)amino]pyrazole-4-carboxamide |
| InChI | InChI=1S/C16H17FN6O3/c1-25-14-5-10(4-13(17)21-14)20-16-11(15(19)24)7-23(22-16)12-8-26-3-2-9(12)6-18/h4-5,7,9,12H,2-3,8H2,1H3,(H2,19,24)(H,20,21,22)/t9-,12+/m1/s1 |
| InChIKey | PRQMBGDYXWVEHE-SKDRFNHKSA-N |
| SMILES | COC1=NC(=CC(=C1)NC2=NN(C=C2C(=O)N)[C@H]3COCC[C@@H]3C#N)F |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
